Dr. Brinda Mayur Dixit, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 516 Innovation Dr, Suite 204, Chesapeake, VA 23320 Phone: 757-277-9927 Fax: 757-277-9928 |
Dr. Sarah Bull Clarkson, M.D. Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 813 Greenbrier Circ, Suite A, Chesapeake, VA 23320 Phone: 757-461-6997 Fax: 757-461-6906 |
Dr. Roger William Lidman, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 816 Greenbrier Cir, Suite A, Chesapeake, VA 23320 Phone: 757-461-6997 Fax: 757-461-6906 |
Dr. Witold Anthony Turkiewicz, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 816 Greenbrier Cir, Suite A, Chesapeake, VA 23320 Phone: 757-461-6997 Fax: 757-461-6906 |
News Archive
NPR's "Shots" blog reports on efforts to determine the source of Haiti's cholera epidemic, writing, "Most researchers currently believe that United Nations peacekeeping soldiers introduced cholera to Haiti in October of 2010," but researchers from the University of Maryland report they "have found two very different cholera strains in some of the first Haitians to be struck by the disease."
Conservative leader Stephen Harper visited Sault Ste. Marie today and said Paul Martin should have said no to Ontario Premier Dalton McGuinty and Liberal campaign chair David Herle about their actual plans for health care instead of manufacturing a false debate on yet-to-be announced health reforms.
Nuvo Research Inc. a specialty pharmaceutical company focused on the research and development of drug products that are delivered into and through the skin using its topical and transdermal drug delivery technologies and on the development of its immune modulating drug candidate WF10, today announced that its European Phase 2 clinical trial evaluating WF10 as a treatment for severe allergic rhinitis met its primary endpoint.
Loyola University Medical Center has earned the coveted Baby-Friendly designation. This verifies that the hospital has implemented the ten steps to help new mothers successfully breastfeed.
Oncolytics Biotech Inc. , currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, and PrECOG LLC, a leading cancer research network, today announced their collaboration in which PrECOG will run the BRACELET-1 (PrE0113) study.
› Verified 4 days ago